Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP961683priorityCriticalpatent/ECSP961683A/en
Publication of ECSP961683ApublicationCriticalpatent/ECSP961683A/en
La presente invención describe nuevos ésteres y amidas farmacológicamente activos de 1,4-piperidina disustituida como antagonista 5-HT4 de fórmula general I (gráfico), en la cual A, X, Y y R tienen los significados especificados en la descripción, procedimientos para su preparación y composiciones farmacéuticas que los contienen.The present invention describes new pharmacologically active esters and amides of 1,4-piperidine disubstituted as 5-HT4 antagonist of general formula I (graph), in which A, X, Y and R have the meanings specified in the description, procedures for their preparation and pharmaceutical compositions containing them.
ECSP9616831996-03-071996-03-07
ESTERS AND AMIDES OF 1,4 DI-SUBSTITUTED PIPERIDINE
ECSP961683A
(en)
USEFUL COMPOUNDS AS THROMBIN INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PEPTIDOMIMETIC AND PEPTIDOMIMETIC SUBSTANCES OF SERINPROTEASE.
INDOL-3-GLIOXILAMIDAS N-SUBSTITUTED WITH ANTI-ASMATIC, ANTI-ALLERGIC AND IMMUNOSUPPRESSOR / IMMUNOMODULATOR EFFECTS, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL STRUCTURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ADAMANTAN DERIVATIVES, PROCEDURES FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION, PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITION, AND THE USE OF SUCH DERIVATIVES FOR THE MANUFACTURE OF MEDICINES
Pharmaceutical compositions for treating disease-related or drug-induced dyskinesias containing piperidine derivatives as nmda receptor antagonist as active ingredient
NEW DERIVATIVES PSEUDOPEPTIDICOS OF ANTAGONIST ACTIVITY OF BRADIQUININA, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.